Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Aspen Pharma Trading Limited, 3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
For use in osteoporosis in post-menopausal women.
Established osteoporosis should have been diagnosed by the following parameters:
Post-menopausal women: 50mg every three weeks.
The duration of treatment depends on the clinical response and the possible occurrence of side-effects.
We would recommend that the effectiveness of therapy be monitored with the appropriate methods for osteoporosis on a 6-12 monthly basis.
Deca-Durabolin should be administered by deep intramuscular injection.
The acute toxicity of nandrolone decanoate in animals is very low. There are no reports of acute overdosage with Deca-Durabolin in the human.
3 years.
Store below 30°C.
Do not refrigerate or freeze.
Store in the original package in order to protect from light.
Deca-Durabolin 50 mg/ml solution for injection: 1 ml type I ampoules sold in packs of 1, 3 or 6 ampoules.
Not all pack sizes may be marketed.
No special requirements for disposal.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
